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Abstract
OBJECTIVE: Inactivation of the Janus kinase 2
(JAK2)/signal transducer and activator of transcrip-
tion 3 (STAT3) signaling axis plays a crucial role in
determining the fate of neural stem cells (NSCs).
Qingnaoyizhi decoction (QNYZD) has been used for
the treatment of vascular dementia and has shown
to improve synaptic remodeling. The aim of this
study was to evaluate the effect of cerebrospinal
fluid (CSF) containing QNYZD (CSF-QNYZD) on the
differentiation of cultured NSCs and the involve-
ment of the JAK2/STAT3 pathway.
METHODS: The protein expression levels of glial fi-
brillary acidic protein (GFAP), tubulin, drosophila
mothers against decapentaplegic protein
(SMAD-1), STAT3, and phosphorylated-STAT3 were
detected by western immunoblot analysis in the
groups: control, CSF, JAK/STAT inhibitor (AG490),
CSF-QNYZD, and CSF-XDZ (CSF-Xidezhen). The dif-
ferentiation of NSCs was determined by immuno-
fluorescence staining. The proliferation of NSCs was
measured using the Cell Counting Kit-8 prolifera-
tion assay.
RESULTS: Compared with the control group,
CSF-QNYZD and AG490 significantly increased the
number and expression of tubulin-positive cells, re-
duced the number and expression of GFAP-positive
cells, and down-regulated the expression of
p-STAT3. However, CSF-QNYZD also decreased the
expression of SMAD-1 and STAT3.
CONCLUSION: Enhanced neuronal differentiation
may be associated with the down-regulation of gli-
al differentiation instead of promoting proliferation
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in treated NSCs. Furthermore, QNYZD may play a di-
rect role in suppressing the formation of GFAP-posi-
tive cells and enhancing neuronal differentiation
by inhibiting JAK2/STAT3 activation. Overall, these
results provide insights into the possible mecha-
nism underlying QNYZD-mediated neurogenesis.
© 2015 JTCM. All rights reserved.
Key words: Neural stem cells; Glial fibrillary acidic
protein; Cell differentiation; Janus kinase 2; STAT3
transcription factor; Qingnaoyizhi decoction
INTRODUCTION
Vascular dementia (VD) is caused by cerebrovascular
disease that indirectly or directly damages the brain
structures associated with cognitive functioning.1,2 Cur-
rent drugs for treating Alzheimer's disease has limited
clinical efficacy on VD.3
Cognitive impairment may be associated with inflam-
mation and the suppression of survival, proliferation,
differentiation, and migration of neural stem cells
(NSCs). NSCs are capable of unlimited self-renewal,
and thus may be a potential therapeutic target for neu-
rological diseases,4 such as VD.
NSCs are proliferative, undifferentiated, and multi-po-
tential cells that undergo extensive self-renewal in the
central nervous system (CNS) and can differentiate in-
to neurons and glia.5 Neuronal differentiation of NSCs
is a potential therapeutic target for neurological diseas-
es.6 However, the low rate of differentiation of NSCs to
neurons is a major obstacle for the successful treatment
of neurological diseases and injuries.7 The cell fate deci-
sion of the NSC is controlled by the combination of in-
trinsic regulatory mechanisms and extrinsic signaling
cues. The Janus activated kinase / signal transducer and
activator of transcription (JAK/STAT) signaling path-
way is a key mediator for NSC differentiation8 and also
regulates astrocytic gene expression. Suppression of as-
trogenesis during the neurogenic phase is crucial for
the generation of a sufficient amount of neurons that is
necessary to build all neuronal layers and linkages in
the brain.9 Silencing of the JAK/STAT signaling path-
way is a key mediator for astrocyte differentiation in
NSCs.10,11
Qingnaoyizhi decoction (QNYZD) is a Chinese medi-
cine. Our previous studies have demonstrated that
QNYZD inhibits the proliferation of smooth muscle
cells and maintains the integrity of tunica intima.12 We
have also shown that QNYZD is neuroprotective
against oxygen deprivation by increasing the activity of
superoxide sismutase (SOD), neuron-specific enolase
(NSE), and cholinesterase (ChE), and decreasing lipid
peroxidase (LPO), and lactate dehydrogenase (LDH)
release13. Furthermore, our studies have shown that
QNYZD improves synaptic remodeling of hypoxia re-
oxygenation (H/R)-exposed cortical neuronal cells via
the regulation of expression of synaptophysin (SYN),
microtubule-associated protein-2 (MAP-2), and
growth-associated protein-43 (GAP-43).14 However,
the effect of QNYZD on the differentiation of NSCs
and the underlying molecular mechanisms are poorly
understood. Activation of JAK2 receptors results in the
phosphorylation and acetylation of STAT3, which is
then dimerized followed by its translocation to the nu-
cleus to activate gene transcription. Therefore, STAT3
activity is critical for astrogenesis.15 In the present
study, we investigated the effect mechanism of cerebro-
spinal fluid (CSF) containing QNYZD (CSF-
QNYZD) on the differentiation and proliferation of
NSCs by examining the JAK2/STAT3 pathway.
METHODS
Animals
The experimental protocol was approved by the ethics
review committee for animal experimentation of Tian-
jin University of Traditional Chinese Medicine (Tian-
jin, China). Experiments were performed in accor-
dance with the international guidelines on the ethical
use of animals. All surgeries were performed under hal-
othane anesthesia. A total of 50 SPF healthy male
adult rabbits weighting 2-2.5 kg (5 months) (Chunle
laboratory animal company, Tianjin, China; Permit
Number: SCXK2009-0004) were used. A total of six
SPF Kun-Ming mice (embryonic day 14.5-15.5)
(SLAC laboratory animal company, Shanghai, China;
Permit Number: SCXK2007-0005) were used.
Preparation of QNYZD and Xidezhen (XDZ) pills
Qingnaoyizhi decoction, consisting of Maidong (Radix
Ophiopogonis Japonici), Renshen (Radix Ginseng),
Shichangpu (Rhizoma Acori Tatarinowii), Danshen (Ra-
dix Salviae Miltiorrhizae), Zhebeimu (Bulbus Fritillari-
ae Thunbergii), Huanglian (Rhizoma Coptidis), and
Bingpian (Borneolum Syntheticum), were purchased
from Baokang hospital affiliated with Tianjin Universi-
ty of Traditional Chinese Medicine (Tianjin, China).
The constituents were soaked in water for 30 min at
room temperature, then heated to boiling point, and
decocted at 100 ℃ for 30 min. After filtration, the re-
maining decoction was concentrated into a crude con-
centration of 2 g/mL, then sterilized and stored at 4 ℃
for further use. XDZ was dissolved in ultra-pure water
to obtain a 0.165 mg/mL solution. Following adaptive
feeding for 7 days, rabbits from the control group, the
XDZ group, and the QNYZD group were respectively
subjected to 2 mL/kg saline, 2 mL/kg XDZ, and 2 mL/
kg QNYZD intragastrically once daily for 3 consecu-
tive days. The CSF was then extracted from these rab-
bits. The administration dose was confirmed by our
previous studies.10 The α-Cyano-(3,4-dihydroxy)-
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N-benzylcinnamide (AG490) was dissolved in dimeth-
yl sulfoxide to obtain a 10 μmol/mL solution.
NSCs culture
NSCs were harvested from the brains of Kun-Ming
mouse embryos (14.5-day), according to Davis et al.16
Briefly, adult mice were anesthetized with halothane,
their uteri removed (under sterile conditions), and
brains isolated from embryonic mice. The vessels and
meninges were carefully removed from the cerebral cor-
tex in ice-cold dissection buffer (Gibco, Grand Island,
NY, USA). The cerebral cortex was then collected in
cold serum-free Dulbecco's modified eagle's medium
with F-12 supplement (DMEM/F-12; Invitrogen,
Carlsbad, CA, USA) and washed in the same medium.
The cerebral cortex was digested by acctuase (Milli-
pore; Billerica, MA, USA) at 37 ℃ for 10 min and
then mechanically dissociated into single cells by filter-
ing the solution through a nylon mesh (70-μm pores).
After washing and centrifugation (1000 × g, 5 min),
cells were re-suspended in neurosphere proliferation
media [DMEM/F12 medium supplemented with 2 %
(v/v) B27, 20 ng/mL epidermal growth factor, 20 ng/
mL basic fibroblast growth factor (bFGF), penicillin,
and streptomycin] and plated at 2 × 105 cells/mL in
T75 culture flasks (Corning, Midland, MI, USA). Af-
ter 6 days in culture, the neurospheres were suspended
in the medium. The resultant neurospheres were har-
vested by accutase (at 37℃ for 5 min), gently dissociat-
ed, and then passaged as single cells in T75 culture
flask with the fresh culture medium at 2.5 × 104 cells/
mL. This subculture was repeated to achieve purified
NSCs and proliferating neurospheres. The third pas-
sage of NSCs was used for the following experiments.
Furthermore, to measure the rate of proliferation, cells
were inoculated in serum-free medium (DMEM/F-12
(1∶1) with bFGF). To estimate NSC differentiation,
the medium was replaced with DMEM/F-12 contain-
ing 4 % fetal bovine serum (FBS) (Sigma-Aldrich; St.
Louis, MO, USA) without bFGF.
Identification of NSCs
NSCs were identified according to zhuang et al.17 Brief-
ly, NSCs were dissociated and then mounted onto
poly-L-lysine coated glass coverslips. After a 24-h at-
tachment period, cells were fixed in 4% paraformalde-
hyde at 4 ℃ for 45 min. The coverslips were rinsed in
0.1 M phosphate-buffered saline (PBS), and then incu-
bated with rabbit anti-nestin antibody (1∶200, Milli-
pore; Billerica, MA, USA) overnight at 4 ℃. Immuno-
reactivity was visualized by anti-rabbit Alexa Fluor con-
jugated secondary antibody (1∶500; Millipore; Billeri-
ca, MA, USA).
Proliferation assay
Proliferation of cortical NSCs was measured by the cell
counting kit-8 (CCK8; Beyotime, Haimen, Jiangsu,
China) according to the manufacturer's instructions.
Briefly, cells were inoculated in 96-well plates (100 μL/
well) (all assays were performed in quadruplicate). Af-
ter CSF-QNYZD exposure from 1 to 3 days, cells were
incubated with the CCK8 solution for approximately 2
h. The formazan product was spectrometrically quanti-
fied using an enzyme-linked immunosorbent assay
reader (at 450nm), and growth curveswere constructed.
Differentiation assay
According to Nie et al,18 the differentiation of cortical
NSCs was measured 2 days after CSF-QNYZD expo-
sure. Cells were mounted onto poly-D-lysine
(PDL)-coated coverslips in 24-well plates at 1 × 104
cells/well with DMEM/F-12 medium plus 4 % FBS,
and then exposed to CSF-QNYZD for 48 h. NSCs
were fixed in 4 % paraformaldehyde for 45 min, gently
rinsed 3 times with PBS, and then blocked with PBS
containing 1 % bovine serum albumin and 0.3 % Tri-
ton for 30 min at room temperature. Cells were subse-
quently incubated overnight at 4 ℃ in mouse anti-neu-
ronal class III β-tublin (1∶500) (Millipore; Billerica,
MA, USA) or rabbit anti-glial fibrillary acid protein
(GFAP; 1∶500) (Millipore; Billerica, MA, USA). Cells
were then incubated with anti-rabbit Alexa Fluor 594
or anti-mouse Alexa Fluor 488 (1∶500) (Millipore; Bill-
erica, MA, USA) at room temperature for 2 h and then
nuclei were stained with 4',6-diamidino-2-phenylin-
dole (DAPI) (Beyotime, Haimen, Jiangsu, China) at
room temperature for 10 min.
Immunocytochemistry
Staining was viewed under the DMI 3000B laser scan-
ning confocal microscope (Leica; Wetzlar, Germany).
Cells counts were performed from images taken with
image software (Media Cybernetics; Silver Spring,
MD, USA). Cells were counted from 8-10 random-
ly-selected visual fields. The percentage of positive cells
(GFAP+ or tubulin+) was calculated as a fraction of the
total number of GFAP+ and tubulin+ cells. Each assay
consisted of at least three independent experiments.
Western immunoblotting
Western immunoblot analysis was performed for cell
specific markers related to JAK2/STAT3 signaling.
Cells were harvested from culture plates 2 days after
CSF-QNYZD exposure and lysed with RIPA lysis buf-
fer (Beyotime; Haimen, Jiangsu, China) followed by
centrifugation at 13 000 ×g for 15 min. The superna-
tant was subsequently heated at 100 ℃ for 15 min and
then cooled on ice for 30 min. The protein concentra-
tions were measured with the Bradford protein assay
kit (Bio-Rad) (Beyotime; Haimen, Jiangsu, China) ac-
cording to the manufacturer's instructions. Equal
amounts of protein were separated (60 V × 40 min →
90 V × 40 min) by 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and then transferred
(0 ℃ , 200 mA × 105 min) onto nitrocellulose mem-
branes (Millipore; Billerica, MA, USA). Membranes
were then blocked with 5% skim milk in 0.1%
Tween-20 in Tris-buffered saline (TBST) at room tem-
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perature for 1 h under gentle shaking. After washing (3
× 10 min) in TBST, membranes were incubated (in
blocking solution, overnight at 4 ℃) with the primary
antibodies: rabbit anti-GFAP (1∶1000) (Cell Signal-
ing,Boston,MA,USA),mouseanti-tubulinβ III (1∶400)
(Cell Signaling), rabbit anti-SMAD1 (1: 1000) (Cell
Signaling), rabbit anti-STAT3 (1∶1000) (Cell Signal-
ing), rabbit anti-phospho-STAT3 (1∶1000) (Cell Sig-
naling). Mouse anti-actin (1∶250) (Sigma-Aldrich, St.
Louis, MO, USA) served as the house-keeping protein.
After washing (3 × 10 min in TBST), the membranes
were incubated (in blocking solution for 1 h) with per-
oxidase-conjugated goat anti-rabbit immunoglobulin
G (IgG) (1∶2000) (Cell Signaling Technology; Beverly,
MA, USA) or peroxidase-conjugated goat anti-mouse
IgG (1∶2000) (Cell Signaling Technology; Beverly,
MA, USA). Immunoreactive bands were visualized us-
ing enhanced chemiluminescence western blotting de-
tection reagents (Millipore; Billerica, MA, USA) and
quantified with Image J software (National Institute of
Health, Bethesda, MD, USA).
Statistical analysis
All data are expressed as the mean ± standard deviation
( xˉ ± s) and were analyzed by one-way analysis of vari-
ance followed by the Levene's post hoc test. Signifi-
cance was reached at values of P < 0.05. Data were ana-
lyzed by SPSS 13.0 (SPSS; Chicago, IL, USA).
RESULTS
NSC identification
Immunostaining of neural stem cell spheres for nestin
revealed that over 98% of the cells were positive for
nestin (Figure 1). Moreover, immunostaining for
GFAP and tubulin showed that these cells were differ-
entiated, thus further confirming their identity as NSC
and the use of this culture for subsequent experiments
(Figure 1).
Effects of CSF-QNYZD on the proliferation of
cultured NSCs
The CCK-8 assay revealed that NSC proliferation in
all five groups increased from days 1 to 2 and de-
creased from days 2 to 3 (Figure 2). NSC proliferation
was significantly (P < 0.05) greater in the CSF
-QNYZD group compared with the control group on
day 1. However, NSC proliferation remained un-
changed in the other three groups compared with con-
trol. NSC proliferation remained unchanged between
the five groups on days 2 and 3. NSCs treated with
AG490 did not affect proliferation on day 1, indicat-
ing that the STAT3 signaling pathway is not involved
in NSC proliferation at this early time-point. NSC pro-
liferation peaked in all groups on day 2, indicating
each of the five treatments induced NSC proliferation
and maintenance. NSC differentiation is required for
proliferation and maintenance of NSCs. Overall, the
results demonstrated that a 2-day exposure of NSCs to
CSF, AG490, CSF-QNYZD, and CSF-XDZ for 2
days is suitable for the investigation of NSC differen-
tiation.
Effect of CSF-QNYZD on the differentiation of
cultured NSCs
After 2 days in differentiation culture medium, numer-
ous cells differentiated from NSCs to mature neurons
and glial cells. Co-immunostaining for tubulin and
GFAP revealed the maturation of neuronal cells and
the formation of glial cells in CSF (Figure 3E-H),
AG490 (Figure 3I-L), CSF-QNYZD (Figure 3, M-P),
and CSF-XDZ (Figure 3Q-T) groups compared with
the control group (Figure 3A-D). Treatment with
AG490, CSF-QNYZD, and CSF-XDZ significantly
(P < 0.05) increased the relative percentage of tubu-
lin-positive cells by 17.19% ± 1.84% , 15.03% ±
2.27% , and 13.40% ± 1.29% , respectively compared
with control (9.27% ± 0.95% ) (Figure 3U). AG490,
CSF-QNYZD, and CSF-XDZ markedly reduced the
relative percentage of GFAP-positive cells to 82.81% ±
1.84%, 84.97% ± 2.27%, and 86.60% ± 1.29%, re-
spectively compared with the control (90.73% ±
0.95 % ) (Figure 3V). Conversely, CSF treatment did
not affect the relative percentage of tubulin-positive
cells (12.23% ± 2.32%) and the relative percentage of
GFAP-positive cells compared with the control
(87.77% ± 2.32% ). Western immunoblots confirmed
these results. The expression of tubulin (Figure 3W,
3Y) was markedly (P < 0.05) enhanced with a 2-day
treatment of AG490 (1.42 ± 0.08), CSF-QNYZD
(1.54 ± 0.13), and CSF-XDZ groups (1.34 ± 0.22)
compared with the control. Conversely, the expression
of GFAP (Figure 3X, Z) was significantly (P < 0.05)
decreased in AG490 (0.56 ± 0.15), CSF-QNYZD
(0.52 ± 0.13), and CSF-XDZ group (0.68 ± 0.08)
compared with the control. However, CSF treatment
did not affect the expression of tubulin (1.11 ± 0.24)
A B C D E
Figure 1 The identification of neural stem cells (NSCs)
A: undifferentiated NSCs (× 10); B: differentiated NSCs (× 10); C: NSCs stained for 4,6-diamino-2-phenyl indole (DAPI) (× 40); D:
NSCs stained for glial fibrillary acidic protein (× 40); E: NSCs stained for nestin (× 40).
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and GFAP (0.92 ± 0.07) compared with the control.
Furthermore, all three treatment groups significantly
(P < 0.05) decreased the expression of GFAP com-
pared with the CSF group. CSF-QNYZD and AG490
treatment significantly (P < 0.05) increased the expres-
sion of tubulin compared with CSF treatment. Howev-
er, the increase in expression of tubulin with
CSF-XDZ was lower than that of the CSF group.
These results suggest that enhanced neuronal differenti-
ation may be associated with down-regulation of
GFAP protein instead of promoting proliferation in
these treated NSCs. Overall, these results suggest that
AG490 suppresses astrogliogenesis of NSCs and en-
hances neurogenesis, thereby indicating that STAT3
may play a crucial role in determining the differentiat-
ed fate of NSCs.
Effect of CSF-QNYZD on JAK2/STAT3 activation of
cultured NSCs
To confirm the involvement of the JAK2/STAT3 path-
way in astrogliogenesis and neurogenesis of NSCs, we
determined the expression of SMAD1, STAT3, and
p-STAT3 in NSCs of all groups. Immunoblot analysis
revealed that p-STAT3 was significantly (P < 0.05)
down-regulated with AG490 (0.57 ± 0.12),
CSF-QNYZD (0.58 ± 0.12) and CSF-XDZ (0.58 ±
0.14) compared with the control (Figure 4D). SMAD1
was also significantly (P < 0.05) reduced with AG490
(0.62 ± 0.14), CSF-QNYZD (0.44 ± 0.05), and
CSF-XDZ (0.43 ± 0.04) compared with the control
(Figure 4B). STAT3 was significantly (P < 0.05) de-
creased with CSF-QNYZD (0.57 ± 0.29) and
CSF-XDZ (0.57 ± 0.17) compared with the control
(Figure 4C). However, AG490 did not affect the ex-
pression of STAT3 (0.69 ± 0.22) compared with the
control. CSF treatment did not affect the expression of
p-STAT3 (0.85 ± 0.26), STAT3 (0.76 ± 0.31), and
SMAD-1 (0.88 ± 0.31) compared with the control.
Compared with the CSF group, AG490,
CSF-QNYZD, and CSF-XDZ significantly (P < 0.05)
reduced the expression of p-STAT3 (Figure 4D).
CSF-QNYZD and CSF-XDZ also markedly (P <
0.05) reduced the level of SMAD-1 compared with
CSF treatment (Figure 4B). However, STAT3 was not
significantly affected by AG490, CSF-QNYZD, and
CSF-XDZ (Figure 4C). Overall, these data indicate
that the suppression of the JAK2/STAT3 signaling
pathway in NSCs may be critical for enhancing neuro-
nal differentiation and suppressing astrogliogenesis.
DISCUSSION
The present study demonstrated that CSF-QNYZD
enhanced neuronal differentiation and suppressed cell
differentiation into the glial lineage, as well as promot-
ed the proliferation of NSCs on first day of treatment.
CSF-QNYZD increased the expression of tubulin and
number of cells expressing tubulin. This effect was reg-
ulated via the inhibition of STAT3 signaling and a re-
duction in the expression of GFAP and the number of
cells expressing this astrocytic marker. Therefore,
CSF-QNYZD may be a potent agent for growth-pro-
moting and differentiation-inducing therapy in NSCs.
We have previously shown that QNYZD improves syn-
aptic remodeling of the Hypoxia/Reoxygenation corti-
cal neurons by regulating the expression of Synapsin,
Microtubule-associated protein-2 and Growth associat-
ed protein-43.10 However, its effects on the differentia-
tion of NSCs in nerve regeneration is limited. The pres-
ent study suggests that CSF-QNYZD may affect nerve
regeneration because this treatment increased the num-
ber of tubulin-positive cells in NSC cultures. Further-
more, QNYZD diminished both the number of
GFAP-positive cells and the promotion of NSCs prolif-
eration. Inhibiting glial differentiation contributes to
the neuronal differentiation in NSCs. Therefore,
QNYZD may improve nerve regeneration partly by
preventing the differentiation of glial cells.
Findings of the current study showed that AG490 in-
creased and decreased the number of tubulin- and
GFAP-positive cells, respectively. AG490 has recently
been shown to suppress astrogliosis and neuronal loss.19,20
Previous studies have demonstrated that STAT3 signal-
ing plays a crucial role in determining NSC fate during
neurodevelopment.21 STAT3-related signaling path-
ways are likely to play a role in neuronal differentiation
and survival during NSC neurogenesis.22 The JAK/
STAT3 signaling pathway enhances STAT3 activity in
NSCs leading to glial differentiation.23 Inhibition of
gene expression or activity of STAT3 markedly reduces
astrogliogenesis.24,25 The JAK/STAT pathway is in-
volved in many cellular processes in the brain, includ-
0.80
0.60
0.40
0.20
0.00
Ab
sor
ban
ce
(O
pti
cal
den
sity
,O
D)
Control
CSF
AG490
CSF-QNYZD
CSF-XDZ
1 2 3
Proliferation days
Figure 2 The effect of different treatments on the prolifera-
tion of neural stem cells
Control: treatment with normal medium; CSF: NSCs treated
with 10 % cerebrospinal fluid; AG490: NSCs treated with
10% AG490; CSF-QNYZD: NSCs treated with 10% cerebrospi-
nal fluid containing Qingnaoyizhi decoction; CSF-XDZ: NSCs
treated with 10% cerebrospinal fluid containing Xidezhen.
Cell proliferation was assessed by the Cell Counting Kit 8 as-
say. aP < 0.05, vs control.
73
JTCM |www. journaltcm. com
WuYQ et al. / Experimental Study
February 15, 2015 |Volume 35 | Issue 1 |
1 2 3 4 5
GFAP
β-actin
kDa
50
45
1 2 3 4 5
Tubulin
β-actin
kDa
55
45
W X
TSRQP
ONMLK
JIHGF
ECB DA
25
20
15
10
5
0 Control CSF AG490 CSF-QNYZD CSF-XDZ
Re
lat
ive
per
cen
tag
eo
ftu
bu
lin
po
siti
ve
cel
ls(
%)
25
20
15
10
5
0 Control CSF AG490 CSF-QNYZD CSF-XDZ
Re
lat
ive
per
cen
tag
eo
fG
FA
P
po
siti
ve
cel
ls(
%)
Groups Groups
2.0
1.5
1.0
0.5
0.0 Control CSF AG490 CSF-QNYZD CSF-XDZ
Re
lat
ive
exp
res
sio
no
ftu
bu
lin
1.2
0.9
0.6
0.3
0.0 Control CSF AG490 CSF-QNYZD CSF-XDZ
Re
lat
ive
exp
res
sio
no
fG
FA
P
Y
ab
ab
ab ab
ab
a
Z
GroupsGroups
Figure 3 Neuronal and glial differentiation of neural stem cells
A-D: control group; E-H: CSF group; I-L: AG490 group; M-P: CSF-QNYZD group; Q-T: CSF-XDZ group. A, E, I, M, Q: DAPI stain-
ing; B, F, J, N, R: tubulin staining; C, G, K, O, S: GFAP staining; D, H, L, P, T: merge staining of tubulin and GFAP. U: quantifica-
tion of tubulin + cells as a relative percentage of the total number of GFAP+ cells and tubulin+ cells. V: quantification of
GFAP+ cells as a relative percentage of the total number of GFAP+ cells and tubulin+ cells. W: representative immunoblot of
tubulin expression in groups; X: representative immunoblot of GFAP expression in groups; 1: control; 2: CSF; 3: AG490; 4:
CSF-QNYZD; 5: CSF-XDZ. Y: quantification of the relative abundance of Tubulin protein; Z: quantification of the relative abun-
dance of GFAP protein. Control group: treatment with normal medium; CSF: NSCs treated with 10% cerebrospinal fluid;
AG490: NSCs treated with 10% AG490; CSF-QNYZD: NSCs treated with 10 % cerebrospinal fluid containing Qingnaoyizhi de-
coction; CSF-XDZ: NSCs treated with 10% cerebrospinal fluid containing Xidezhen. aP < 0.05, vs control; bP < 0.05, vs CSF.
U
ab a
a ab
a a
V
74
JTCM |www. journaltcm. com
WuYQ et al. / Experimental Study
February 15, 2015 |Volume 35 | Issue 1 |
ing cell growth and differentiation, immune functions,
and synaptic plasticity.26
The major new findings of this study was that
QNYZD treatment inhibited astrogliogenesis, and
down-regulated the downstream proteins: SMAD-1,
STAT3, and p-STAT3. Overall, these findings suggest
that QNYZD promotes neuronal differentiation of
NSCs by preventing astrogliogenesis, at least in part,
by inhibiting the activation of the JAK/STAT signaling
pathway.
Inactivation of the JAK2/STAT3 signaling axis plays a
critical role in cognitive impairment.27 Therefore, find-
ings from the current study and our previous work in-
dicate that QNYZD may be an attractive therapy for
CNS regeneration in cognitive impairment by stimulat-
ing the proliferation of endogenous and transplanted
NSCs and improving synaptic plasticity. Overall,
QNYZD may prevent or reduce gliosis and improve
neurogenesis by regulating the CSF microenvironment
after brain and spinal cord injury.
A limitation of the present study was the sequential
generation of neurons and astrocytes from the same
pool of NSCs. Tightly regulating the neuron-to-astro-
cyte switch is critical for the generation of a balanced
number of astrocytes and neurons and neuronal circuit
formation. Furthermore, our study did not determine
the molecular aspects of the JAK2/STAT3 pathway spe-
cifically affected by QNYZD given that the microenvi-
ronment and transcriptional regulators of the CSF may
have contributed to the effect of QNYZD on glial dif-
ferentiation of NSCs. Other signaling pathways may
have also played a role in QNYZD-mediated inhibi-
tion of glial differentiation. Therefore, further investiga-
tions should also focus on the alterations of the CSF
microenvironment because it may provide other effec-
tive strategies to overcome the barrier of the low neuro-
nal differentiation rate of NSCs. Another limitation of
this study our experiments were only performed under
in vitro conditions.
The results from the present study may provide a novel
treatment strategy for cognitive impairment induced
by VD. However, further studies are needed to address
the benefit of QNYZD on the microenvironment as a
therapy for neurogenesis in VD. In conclusion, our
findings suggest that QNYZD stimulates neurogenesis
and suppresses astrogliogenesis in cultured NSCs, at
least in part, by inhibiting the activation of the JAK/
STAT signaling pathway.
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Figure 4 Expression of drosophila mothers against decapentaplegic protein (SMAD-1), signal transducers and activators of tran-
scription (STAT3) and phosphorylation of signal transducers and activators of transcription (p-STAT3)
A: representative immunoblot of SMAD-1, STAT3 and p-STAT3 in groups; 1: control; 2: CSF; 3: AG490; 4: CSF-QNYZD; 5: CSF-XDZ.
B-D: quantification of the relative abundance of SMAD-1, STAT3, and p-STAT3; B: SMAD-1; C: STAT3; D: p-STAT3. Control group:
treatment with normal medium; CSF: NSCs treated with 10 % cerebrospinal fluid; AG490: NSCs treated with 10 % AG490;
CSF-QNYZD: NSCs treated with 10 % cerebrospinal fluid containing Qingnaoyizhi decoction; CSF-XDZ: NSCs treated with 10% ce-
rebrospinal fluid containing Xidezhen. aP < 0.05, vs control; bP < 0.05, vs CSF.
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